Literature DB >> 14510477

Control of siRNA expression utilizing Cre-loxP recombination system.

Vivi Kasim1, Makoto Miyagishi, Kazunari Taira.   

Abstract

Vector-mediated systems for specific siRNA expression in mammalian cells using pol III promoters allowing high level of transcription activity have been developed in the past years, widening the usage of RNA interference (RNAi). In this study, we controlled the pol III promoter (U6 promoter)-driven expression of siRNA using the Cre-loxP system. Our "Cre-On" siRNA-expression vector against firefly luciferase activity could be switched on only in the presence of Cre recombinase, which, in this study, was delivered directly from the medium into the cells as TAT-NLS-Cre, a fusion protein with TAT peptide (an Arg rich peptide derived from HIV) and nuclear localizing signal (NLS). Upon the addition of TAT-NLS-Cre, complete and functional siRNAs were generated and reporter activity was suppressed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14510477     DOI: 10.1093/nass/3.1.255

Source DB:  PubMed          Journal:  Nucleic Acids Res Suppl


  4 in total

1.  CRE recombinase-inducible RNA interference mediated by lentiviral vectors.

Authors:  Gustavo Tiscornia; Vinay Tergaonkar; Francesco Galimi; Inder M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-30       Impact factor: 11.205

2.  Efficient shRNA-mediated inhibition of gene expression in zebrafish.

Authors:  Gianluca De Rienzo; Jennifer H Gutzman; Hazel Sive
Journal:  Zebrafish       Date:  2012-07-12       Impact factor: 1.985

3.  Selection of potent non-toxic inhibitory sequences from a randomized HIV-1 specific lentiviral short hairpin RNA library.

Authors:  Carola Pongratz; Benjamin Yazdanpanah; Hamid Kashkar; Maik J Lehmann; Hans-Georg Kräusslich; Martin Krönke
Journal:  PLoS One       Date:  2010-10-08       Impact factor: 3.240

4.  Strategies for designing transgenic DNA constructs.

Authors:  Chengyu Liu
Journal:  Methods Mol Biol       Date:  2013
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.